Wockhardt, one of the leading drug makers, witnessed a massive fall in share prices on Friday after the reports stated the company received form 483 from US FDA for Shendra plant. The drug regulator has reported made 9 observations.

Shendra plant inspection was ended on January 14. As per reports, the company is expected to respond to US FDA with corrective measures in the next 15 days.

Shares of Wockhardt are trading at Rs 1,358.40, down Rs 157, or 10.36% at the Bombay Stock Exchange (BSE) on Friday at 12:12 p.m.

Total volume of shares traded on the bourses today was higher by 156.39% to 2,422,816 compared with 22-day average volume of 944,966.